CIMETIDINE HYDROCHLORIDE (cimetidine hydrochloride) by Inpharmus is clinical pharmacology cimetidine competitively inhibits the action of histamine at the histamine h 2 receptors of the parietal cells and thus is a histamine h 2 receptor antagonist. Approved for of symptoms. First approved in 2000.
Drug data last refreshed 23h ago
CLINICAL PHARMACOLOGY Cimetidine competitively inhibits the action of histamine at the histamine H 2 receptors of the parietal cells and thus is a histamine H 2 receptor antagonist. Cimetidine is not an anticholinergic agent. Studies have shown that cimetidine inhibits both daytime and nocturnal…
Worked on CIMETIDINE HYDROCHLORIDE at Inpharmus? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.